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Background: Electrocautery applications in surgical operations produce evasive odorous smoke in the cleanest
operation rooms. Because of the incomplete combustion of electrical current in the tissues and blood vessels
during electrocautery applications, electrocautery smoke (ES) containing significant unknown chemicals and
biological forms is released. The potential hazards and cancer risk should be further investigated from the
perspective of the occupational health of surgical staff.
Methods: The particle number concentration and the concentration of polycyclic aromatic hydrocarbons (PAHs) in
ES were thoroughly investigated in 10 mastectomies to estimate the cancer risk for surgical staff. The particle
number concentration and gaseous/particle PAHs at the surgeons’ and anesthetic technologists’ (AT) breathing
heights were measured with a particle counter and filter/adsorbent samplers. PAHs were soxhlet-extracted, cleaned,
and analyzed by gas chromatography/mass spectrometry.
Results: Abundant submicron particles and high PAH concentrations were found in ES during regular surgical
mastectomies. Most particles in ES were in the size range of 0.3 to 0.5 μm, which may potentially penetrate
through the medical masks into human respiration. The average particle/gaseous phase PAH concentrations at the
surgeon’s breathing height were 131 and 1,415 ng/m3, respectively, which is 20 to 30 times higher than those in
regular outdoor environments. By using a toxicity equivalency factor, the cancer risk for the surgeons and
anesthetic technologists was calculated to be 117 × 10-6 and 270 × 10-6, respectively; the higher cancer risk for
anesthetic technologists arises due to the longer working hours in operation rooms.
Conclusions: The carcinogenic effects of PAHs in ES on the occupational health of surgical staff should not be
neglected. The use of an effective ES evacuator or smoke removal apparatus is strongly suggested to diminish the
ES hazards to surgical staff.
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Although operation rooms (ORs) in medical facilities are
regarded as the cleanest environments because of surgical
sterility requirements, surgical smoke produced by the use
of electrocautery or laser systems is inevitable in modern
surgery and potentially harmful to surgical personnel
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reproduction in any medium, provided the orprocess of electrocautery or laser applications for tissue
dissection and vessel coagulation generates a noticeable
noxious plume with an undesirable odor, and gaseous and
aerosol emissions from the patient’s surgical field. Electro-
cautery smoke (ES) contains various carcinogens and may
pose unknown cancer risks for the nearly one million
surgical staff around the world [2].
Airborne particles have consistently been associated with
adverse cardiovascular health outcomes [3]. In ORs, surgi-
cal smoke, consisting of chemical gases and particles with
various sizes, raises potential health concerns to surgicaltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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smoke, contaminants such as hydrocarbons, phenols,
nitriles, fatty acids, acrylonitrile, and carbon monoxide
[4,5] and viable cellular elements [6-8] pose potential
acute or long-term health hazards to surgical staff. The
ES released during reduction mammoplasty was found
to be mutagenic to the TA98 strain by the Ames tests
[9]. Regardless of the apparent cleanliness and sterility
of ORs, viral infection and the long-term health effects
of chemicals in surgical smoke have drawn increasing
attention from surgical personnel [10] as well as pa-
tients that have undergone surgery [11]. Smoke evacu-
ation in ORs has been strongly suggested to minimize
exposure and related effects on health [1,12].
In the OR, surgical smoke produced by electrocautery
or laser applications during surgery emits tremendous
amounts of particles and gases into the surrounding air.
The contaminated air first passes through the OR corner
vents, and is then filtered by the high efficiency particu-
late air filters (HEPA) and re-circulated in the OR. HEPA
efficiency and the air exchange rate determine OR air
quality. In general, particle number concentration is a
good indicator to reveal the air quality and sterility in
different ORs. However, the polluting gases in the OR
should not be neglected because HEPA can only effectively
remove airborne particles.
Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous
environmental pollutants and are the main byproducts of
incomplete combustion. The exposure and the related car-
cinogenic effects of PAHs have been widely investigated
[13,14]. Applications of high-frequency electrocautery in
cutting and coagulation modes produce odorous smoke
from tissue pyrolysis, which may contain significant
amounts of PAHs. PAHs are distributed between gaseous
and particle phases based on electrocautery power,
temperature, particle concentration, molecular weight,
etc. Both gaseous and particle-bound PAHs enter the
human lung to a certain extent during respiration, and
further induce a potential health threat. The US Environ-
mental Protection Agency has listed 16 typical PAHs [15]
as priority chemicals because of their toxicity and carcino-
genic effects [16].
Among these PAHs, benzo[a]pyrene (BaP) is the most
significant carcinogenic compound [17] and is often used
as an indicator of cancer risk for target populations.
Toxicity equivalency factors (TEFs) were recommended
for calculating the relative toxicity of individual PAHs to
BaP for the purpose of simplifying risk assessment [18].
This paper investigated particle number concentrations,
size distribution, and gaseous and particle phase PAHs
as the tracers of surgical smoke in ORs. By investigating
PAH concentrations for different surgical personnel and
BaP unit risk, the potential cancer risk for surgical staff
exposed to ES can be estimated.Methods
Sampling
ORs with similar dimensions and air exchange rates at
two different hospitals were selected as the sampling
environments. In order to collect detectable ES samples,
mastectomy was selected as the target operation because
of the longer operation time and noteworthy electrocautery
usage. Since the clean room classification is a general guide-
line of environmental cleanliness and sterility for various
ORs in hospitals, ORs with a clean room level of 104
(particle number concentration with particle size greater
than 0.5 μm should be less than 104/ft3) were chosen for
mastectomy investigation in this study.
For sampling consistency and further comparison
between different mastectomies, the electrocautery power
was kept at 25 W under the coagulation mode throughout
the entire study. Fourteen mastectomies were investigated
by collecting ES gas/particle samples. According to the
results of 2-hour pretest mastectomy, electrocautery usage
time was scrupulously recorded with a laser portable
particle counter (Met One, Grants Pass, Oregon, USA)
monitoring particle number concentrations of particle
50% cut-sizes from 0.3, 0.5, 1, 3, 5, and 10 μm at an
interval of 5 minutes until the end of surgery.
For the purpose of investigating surgical staff exposure
to ES, air samples were taken within 30 cm at the breath-
ing height of the surgeons and the anesthetic technologist
(AT) without contacting the sterile region. Air samples,
including particle and gaseous phases, were collected at
the sampling flow rate of 30 L/min. The ES air was first
passed through a 47-mm quartz fiber filter to collect
smoke aerosols, and then polluted gases were trapped
by the polyurethane foam of PUF-XAD-PUF adsorbent.
Before surgical operation, background air samples were
also collected for comparison. This study was approved
by the Institutional Review Board and Ethics Committee
in our hospital. Informed consent was obtained from all
patients.
PAH analysis
The PAH chemical analysis protocol included soxhlet and
sonication extraction, solvent exchange, cleanup, nitrogen
blow down, and the final gas chromatography/mass
spectrometry (GC/MS) analysis. Prior to sample solvent ex-
traction, samples for PAHs were spiked with a deuterium
surrogate solution containing 10 ng of d8-naphthalene,
d10-fluorene, d12-chrysene, and d12-perylene to moni-
tor efficiency throughout the entire analytical process. A
sonication method was modified to extract particle-bound
PAHs from quartz fiber filter samples, while PUF-XAD-
PUF adsorbent samples were soxhlet-extracted for 24 hours.
This was followed by a solvent exchange to hexane, cleanup
with 5% water deactivated silica gel, and nitrogen blow
down to about 100 μL. Before GC/MS, a deuterium
Table 1 Data related to surgical smoke during mastectomies




PAH concentration for surgical personnel (ng/m3)
Surgeons AT
Gas Particle Gas Particle
1 48 16.8 1,074 59 874 65
2 148 51.2 2,148 205 1,074 73
3 74 25.1 1,592 98 1,041 68
4 125 42.4 2,257 104 2,124 213
5 119 41.7 2,062 236 2,199 214
6 105 35.8 487 98 508 119
7 114 37.1 753 93 190 86
8 136 48.2 1,124 98 316 134
9 51 18.6 1,297 147 1,305 148
10 43 14.2 1,360 168 1,307 168
Mean ± standard deviation 96 ± 39 33.1 ± 13.5 1,415 ± 598 131 ± 57 1,094 ± 682 129 ± 57
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phenanthrene, d10-pyrene, and d12-BaP was injected
to analyze PAHs both qualitatively and quantitatively.
A Hewlett-Packard gas chromatography (GC, Model
6890) equipped with a mass selective detector (MS,
Hewlett-Packard Model 5973) was used to quantify PAHs.
The GC/MS was tuned weekly with 1 ng/μL decafluorotri-
phenylphosphine. A 30 m × 0.25 mm identity column of
0.25-μm film thickness DB-5MS phase (J&W Scientific,
Folsom, CA, USA) was used to separate PAHs. A splitless
injection system was used, with a 2-minute delay before
purge. Helium was the carrier gas, operated at a constant
linear velocity of 25 cm/second. The injector and transfer
line were maintained at 290°C and 300°C, respectively.
The GC temperature program was 50°C for one minute,
20°C/minute to 300°C, and maintained for 15 minutes; the
sample injection volume was 1 μL. Selective ion monitor-




























Figure 1 Total particle number concentration and electrocautery usagThe PAHs analyzed in this study included naphthalene,
acenaphthylene, acenaphthene, fluorine, phenanthrene,
anthracene, fluoranthene, pyrene, benzo[a]anthracene,
chrysene, benzo[b]fluoranthene, benzo[k]fluoranthene,
BaP, indeno[c,d]pyrene, dibenzo[a,h]anthracene, and benzo
[g,h,i] perylene. In addition, hetero-PAHs, including oxygen,
sulfur, and nitrogen, were also detected: 2,3 benzofuran,
dibenzofuran, dibenzothiophene, 7,8 benzoquinolene, and
carbazole.
In order to positively identify trace level PAHs, a final
sample volume of approximately 100 μL and GC/MS de-
tection limits of approximately 3 to 25 pg of individual
PAHs per injection were achieved. The significance of
PAH concentration above the method detection limit
was checked by evaluating field and laboratory blanks,
and spiked PAH recovery. The method detection limit
was determined as three times the standard deviation




















































Figure 2 Particle number size distribution at the surgeon’s breathing height. Particle sizes of 0.3 and 0.5 μm dominate the total particle
number concentrations.
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Field blanks, laboratory blanks, and spike tests were per-
formed to ensure the sampling and analytical background
consistency throughout the study. The blank levels were
less than 0.85% of the total PAH concentration level in
OR samples. Based on the surrogate recoveries, the average
PAH recovery efficiency was 85% (52% to 114%). All PAH
concentrations were corrected by the corresponding surro-
gate PAH recovery efficiencies and field blanks. Particle-
bound and gaseous PAH concentrations were determined
by dividing the individual PAH mass by the sampled air
volume. SPSS 12.0 was used in statistical analysis.
Results and discussion
Electrocautery smoke (ES) monitoring in operating
rooms (ORs)
ES was highly related to the original application; therefore,






































Figure 3 Total particle number concentrations at the breathing heighfor its pollution level. Table 1 shows electrocautery usage
times for mastectomy at two hospitals, which occupied
about one-third of the total operational time. The continu-
ous electrocautery usage produced tremendous amounts of
visible smoke particles and invisible gases in the OR air.
To assess the pollution level of ES, particle number
concentration was used as an indicator of the air quality
at various OR locations, such as the clean air from the
HEPA, the air under the surgical lamp where surgeons
stand, at the AT position, etc. During the mastectomy,
the particle number concentrations of the air under the
surgical lamp reached the level of 106/ft3 (Figure 1).
Compared with the downwash clean air from the HEPA,
with particle number concentrations below 103/ft3, the
enormous amount of particles and gases in ES increased
excess inhalation by the surgical personnel and posed
potential health hazards. With the existence of particle-
bound hazardous substances, particle size becomes even0 35 40 45 50 55 60 65 70
gical elapse (minute)
ts of the surgeons and ATs.
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human respiratory system.
In ES, the majority of airborne particles were 0.3 μm
in size and amounted to 70% of total particles (Figure 2).
Submicron particles have been regarded as respiratory
particles that may penetrate deep into the bronchiole and
alveoli of the lung and subsequently result in various
degrees of lung diseases [19]. Particles of various sizes
in the air were critical for assessing the surgical staff ’s
respiratory exposure. The particle number distribution
at various sizes showed that the average number mean
diameter of ES was 0.35 μm (95% confidence interval:
0.32 to 0.38 μm). Thus, 0.3-μm particles could be chosen




































































































































Figure 4 Concentration of gaseous- and particle-phase PAHs at the bAmong the OR locations, the highest particle number
concentrations (reaching 1.2 × 106/ft3) were found in the
surgeon’s breathing zone right under the surgical lamp,
followed by the AT position. It is probable that the down-
wash air from the HEPA was hindered by the surgical
lamp, and smoke recirculation was also induced by the
heat from the lamp. Shifting the surgical lamp aside to
enhance the clean air downwash to the stagnant ES
under the surgical lamp was suggested to minimize such
a polluted scenario.
PAH levels of electrocautery smoke in the OR
After ES enters the OR air, the downwash clean air from




































































































reathing heights of the surgeons (A) and ATs (B).
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personnel. The coincident patterns of particle number
concentrations at the surgeon and AT breathing heights
(Figure 3) indicated that the ES plume disperses from the
surgical site to the entire OR area instantaneously. The ES
inhalation health threat to other surgical staff should not
be neglected. Compared with the PAH background level
before surgery in the OR (PAHGas = 23.4 ± 8.6 ng/m
3,
PAHParticle = 1.2 ± 0.3 ng/m
3), the particle and gaseous
PAH concentrations for the surgeons and the AT increased
by nearly 40 to 100 times. The inhalation of carcinogenic
PAHs in ES could further deteriorate the health of surgical
personnel during mastectomy in the long-term occupa-
tional viewpoints.
In further analyses of the two hospitals involved in the
study and different mastectomy operations, no statistical
correlation was found between operation time, electro-
cautery usage time, and PAH concentrations. The air
exchange rate (AER), which is controlled by the positive
pressure and ventilation setups in ORs, is a critical param-
eter used to avoid contamination of the patient’s wounds.
The AERs, determined by operational categories and
necessary requirements, are difficult to measure onsite



















Calculated lifetime cancer risk (×10-6) based on 24-hr exposurea
Risk of unit-hour exposure (×10-6)
Average operation time (hour/day)
Estimated lifetime cancer risk (×10-6)
aCalculated risk based on BaPeq unit risk of 8.7 × 10
−5 (ng/m3)−1. ND, not detected.the PAH concentrations. A higher AER could effectively
dissipate the ES pollution and decrease the particle and
PAH concentrations. The consistent particle and gaseous
PAH concentration results at different hospitals and in
various scales of mastectomy operations revealed that the
ES pollution level was statistically the same, and could be
further applied in assessing the risk to surgical personnel.
Figure 4 shows the concentrations of the particle and
gaseous PAHs for the surgeon and the AT. Since the ES
emission source was around the patient’s open wound
during surgery and the surgeon was at the closest position,
it is not surprising that the surgeon was exposed to higher
levels of PAHs, roughly 1.5 times higher than that for the
AT. The similarity of PAH patterns between these two
major surgical personnel indicated that the ES exposure to
the surgical team was from the electrocautery usage.
The downwash clean air from the HEPA may not only
dissipate the smoke, but also disperse ES to the surround-
ing area, resulting in the homogeneous PAH exposure to
surgical personnel in ORs.
Cancer risk of PAH exposure for surgical personnel
Compared with the background PAH concentrations
in ORs, the ES pollution scenario substantially increasesATs in the OR
Surgeon AT
PAHGas PAHParticle PAHGas PAHParticle
1055 1.6 584 1.1
5.8 ND 3.5 ND
19.9 ND 14.6 ND
55.4 0.8 42.2 0.5
84.3 3.2 68.3 2.2
22.2 5.6 16.7 4.0
18.9 3.8 14.2 2.7
17.8 5.4 13.3 4.1
ND 2.7 ND 1.3
ND 3.0 ND 1.4
ND 2.6 ND 1.3
ND 1.5 ND 0.7
ND 1.7 ND 1.1
ND 1.8 ND 1.0
ND 1.8 ND 1.1
ND 2.1 ND 1.5
1.5 11.4 0.9 7.2
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to an average of 16 typical PAHs in the gaseous and
particle phases were 1,279 and 37 ng/m3, respectively.
Though gaseous PAH concentrations were 30 times
higher than those associated with particles, it should
be noted that high molecular weight PAHs often result
in higher carcinogenic effects [20].
BaP has been widely investigated for its mutagenic
effects and is regarded as the most likely carcinogen in
the PAH group. TEFs for various pollutants to a spe-
cific well-known toxic chemical are commonly used in
the dose–response relationship of risk assessment [18].
Based on the possible health effects of ubiquitous PAHs,
TEFs for 16 typical PAHs were applied to estimate the
relative carcinogenic effects. By combining the unit risk of
BaP, 8.7 × 10-5 (ng/m3)-1, and the corresponding gaseous
and particle PAHs in the target environments, cancer
risk for a 70-year lifetime exposure can be estimated.
For surgical personnel, the cancer risk should be modified
to unit-hour exposure risk based on their professional
working time.
Table 2 lists the risk associated with gaseous and particle
PAHs for both surgeons and ATs as the representatives of
surgical personnel. The total lifetime cancer risks to
the surgeons and ATs were 46.8 and 29.3 × 10-6 per
hour exposure, respectively. The surgeons have a higher
risk because of closer contact to the ES. Though the AT
hourly exposure risk was 62% of that for the surgeons, the
longer working time in the OR increased the risk consider-
ably. Based on the unit-hour cancer risks and the associated
working hours, the 70-year lifetime cancer risks for the sur-
geons and ATs are 117 × 10-6 and 270 × 10-6, respectively,
which are significantly higher than the WHO recom-
mended safety level of 1 × 10-6. Such facts indicate that
the ES hazards to surgical personnel in ORs should not be
neglected.
Though the gaseous PAH concentrations outnumbered
the particle-bound PAHs, the major cancer risk posed
by particles (89%) shows that the ES particles should
be treated with the highest priority in the removal of
these health-threatening hazards. However, the cancer
risk related to gaseous PAHs might be underesti-
mated due to the contribution of the hetero-PAHs.
The abundant hetero-PAHs in ES, such as 2,3-benzo-
furan, dibenzofuran, dibenzothiophene, 7,8-benzoqui-
nolene, and carbazole, were also found in the gaseous
phase. Hetero-PAHs are likely adapted by metabolic
processes and therefore have a greater tendency to in-
duce mutation or carcinoma. Though the HEPA can
remove particles in recirculated air, gaseous pollutants
may penetrate through filters and accumulate in the
OR air. Effectively removing ES in ORs should be empha-
sized to minimize the potential adverse health effects to
surgical personnel.Conclusions
Submicron particles in ES in the ORs during modern
surgery are an inevitable nuisance and contain carcinogenic
chemicals. In measuring particle number concentrations at
various size ranges in mastectomy, more than 70% of ES
particles were found to be smaller than 0.3 μm, indicat-
ing that the particles may threaten the health of surgical
personnel through respiration. The ES exposure for sur-
geons and ATs has been fully investigated by measuring
the PAH concentrations in both the gaseous and particle
phases in their breathing zones. Based on TEFs, this study
estimated that the average cancer risk in a 70-year lifetime
for surgeons and ATs was estimated to be 117 × 10-6 and
270 × 10-6, respectively. Effective smoke extractors in the
ORs or high-efficiency masks are suggested to minimize
potential health hazards to surgical personnel.
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